Camp4 Therapeutics Corporation
CAMP
$1.45
-$0.09-5.84%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 31.60% | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 31.60% | -- | |||
| Cost of Revenue | 1.50% | 3.03% | |||
| Gross Profit | 0.60% | 3.69% | |||
| SG&A Expenses | -18.72% | 22.97% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -4.96% | 8.66% | |||
| Operating Income | 6.66% | -3.83% | |||
| Income Before Tax | 6.37% | 1.52% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 6.37% | 1.52% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 6.37% | 1.52% | |||
| EBIT | 6.66% | -3.83% | |||
| EBITDA | 6.88% | -3.95% | |||
| EPS Basic | 19.86% | 96.82% | |||
| Normalized Basic EPS | 19.85% | 96.82% | |||
| EPS Diluted | 19.86% | 96.82% | |||
| Normalized Diluted EPS | 19.85% | 96.82% | |||
| Average Basic Shares Outstanding | 16.83% | 2,994.73% | |||
| Average Diluted Shares Outstanding | 16.83% | 2,994.73% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||